Remote Patient Monitoring System Market – Global Industry Trends and Forecast 2022 to 2030

The global remote patient monitoring system market size was valued at USD 1,280.0 million in 2021, and is predicted to be worth around USD 5.7 billion by 2030, registering a CAGR of 20.1% during the forecast period 2022 to 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/39198

Growth Factors

COVID-19 pandemic has a significant impact on the remote patient monitoring system. The main drivers for this market are the increasing geriatric population, cost-effective treatment, and the rising prevalence of chronic conditions. The breakout of Covid-19 has propelled the demand for remote patient monitoring devices and services as healthcare facilities were burdened with Covid-19 infected patients. Key players like Smiths Medical reported that the demand of their home monitoring devices substantially increased during the pandemic.

The amalgamation of telehealth with remote patient monitoring services is expected to further boost market growth. Asia Pacific is also projected to be a key revenue generator in the coming years. The region is backed by developing countries such as China, South Korea, and Thailand which are witnessing an increase in the number of chronic diseases owing to lifestyle changes.

Report Coverage

Report Scope Details
Market Size US$ 5.7 billion by 2030
Growth Rate CAGR of 20.1% From 2022 to 2030
Largest Market North America
Base Year 2021
Forecast Period 2022 to 2030
Segments Covered Product, Application, End use
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Nihon Kohden Corporation; Omron Corporation; OSI Systems, Inc.; Koninklijke Philips N.V.; F. Hoffmann-La Roche Ltd; Welch Allyn; Smiths Medical; Abbott; Boston Scientific Corporation; Dräger Medical; GE Healthcare; Honeywell; Johnson & Johnson; LifeWatch; Medtronic; Masimo; Vitls, Inc.; CareValidate; Biotronik; American Telecare

By Product Analysis

The vital sign monitors are commonly used, and the segment is expected to witness the fastest growth rate of 21.9% in the market for remote patient monitoring system over the forecast period. Heart rate monitor is identified as the dominating product sub-segment due to the increasing incidence of cardiac conditions globally. The surge in the number of individuals with heart disorders has led to the increased usage of these monitors.

The surge in the number of individuals with heart disorders has led to the increased usage of these monitors. In 2019, Withings introduced the most advanced and diverse home cardiovascular monitors at CES. It is expected to be the first product that measures BP and records ECG and heart readings via a digital stethoscope in one device.

By Application Analysis

Diabetes emerged as the leading application segment in 2021 and accounted for over 12.8% of the revenue share. Diabetes is one of the leading causes of death, which requires continuous monitoring of blood glucose levels. It is known to affect various functions of the body including heart activity, vision, liver function, and renal activity.

The hypertension application segment is also expected to witness significant growth over the forecast period. Hypertension increases the risk of cardiovascular diseases. According to the World Health Organization (WHO), over 1.0 billion people have hypertension worldwide.

By End-use Analysis

The hospital-based patient segment was the leading end-use segment in 2021 and accounted for 79.4% of the revenue share. Hospitals cater to a large number of outpatients as well as inpatients. They offer a large number of diagnostic tests and have a larger technical staff for catering to the needs of the patients.

A large patient pool and an increasing number of tests being performed are the vital drivers for segment growth. Hospital patients are admitted to facilities in need of acute care and therefore it is vital to keep a continuous check on the vital parameters of patients.

The cost-efficiency of this alternate site along with the availability of qualified resources is expected to support the growth. In addition, considering the increasing strain on hospital resources and personnel, remote patient monitoring presents market players with huge opportunities in terms of partnering with hospitals and other healthcare settings and launching new products to facilitate affordable care at a patient’s home.

By Regional Analysis

North America dominated the remote patient monitoring system market and accounted for the largest revenue share of 41.6% in 2021. The increase in the incidence of chronic diseases, demand for wireless and portable systems coupled with the presence of sophisticated reimbursement structures aimed at cutting out-of-pocket expenditure are the major factors attributed to the regional growth.

In Asia Pacific, the market is expected to witness the fastest CAGR over the forecast period owing to the presence of untapped opportunities in the emerging markets of India and China. Japan is expected to be a key revenue generator owing to its wide old age (65+) population.

Key Players

  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Nihon Kohden Corporation
  • Omron Corporation
  • OSI Systems, Inc.
  • Koninklijke Philips N.V.
  • F. Hoffmann-La Roche Ltd
  • Welch Allyn
  • Smiths Medical
  • Abbott
  • Boston Scientific Corporation
  • Dräger Medical
  • GE Healthcare
  • Honeywell
  • Johnson & Johnson
  • LifeWatch
  • Medtronic
  • Masimo
  • Vitls, Inc
  • CareValidate
  • Biotronik
  • American Telecare

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/39198

Market Segmentation

  • By Product
    • Vital Sign Monitors
      • Blood Pressure Monitors
      • Pulse Oximeters
      • Heart Rate Monitor (ECG)
      • Temperature Monitor
      • Respiratory Rate Monitor
      • Brain Monitoring (EEG)
    • Special Monitors
      • Anesthesia Monitors
      • Blood Glucose Monitors
      • Cardiac Rhythm Monitor
      • Respiratory Monitor
      • Fetal Heart Monitors
      • Prothrombin Monitors
      • Multi-Parameter Monitors (MPM)
      • Others
  • By Application
    • Cancer
    • Cardiovascular Diseases
    • Diabetes
    • Sleep Disorder
    • Weight management and Fitness Monitoring
    • Bronchitis
    • Infections
    • Virus
    • Dehydration
    • Hypertension
  • By End-use
    • Hospital Based Patients
    • Ambulatory Patients
    • Home Healthcare
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
    • Asia Pacific
      • China
      • Japan
      • India
      • Thailand
      • South Korea
    • Latin America
      • Mexico
      • Brazil
      • Argentina
      • Colombia
    • MEA
      • South Africa
      • Saudi Arabia
      • UAE

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Remote Patient Monitoring System Market, By Product

7.1.  Remote Patient Monitoring System Market, by Product, 2021-2030

7.1.1.    Vital Sign Monitors

7.1.1.1.        Market Revenue and Forecast (2019-2030)

7.1.2.    Special Monitors

7.1.2.1.        Market Revenue and Forecast (2019-2030)

Chapter 8.  Global Remote Patient Monitoring System Market, By Application

8.1.  Remote Patient Monitoring System Market, by Application, 2021-2030

8.1.1.    Cancer

8.1.1.1.        Market Revenue and Forecast (2019-2030)

8.1.2.    Cardiovascular Diseases

8.1.2.1.        Market Revenue and Forecast (2019-2030)

8.1.3.    Diabetes

8.1.3.1.        Market Revenue and Forecast (2019-2030)

8.1.4.    Sleep Disorder

8.1.4.1.        Market Revenue and Forecast (2019-2030)

8.1.5.    Weight management and Fitness Monitoring

8.1.5.1.        Market Revenue and Forecast (2019-2030)

8.1.6.    Bronchitis

8.1.6.1.        Market Revenue and Forecast (2019-2030)

8.1.7.    Infections

8.1.7.1.        Market Revenue and Forecast (2019-2030)

8.1.8.    Virus

8.1.8.1.        Market Revenue and Forecast (2019-2030)

8.1.9.    Dehydration

8.1.9.1.        Market Revenue and Forecast (2019-2030)

8.1.10.  Hypertension

8.1.10.1.      Market Revenue and Forecast (2019-2030)

Chapter 9.  Global Remote Patient Monitoring System Market, By End User

9.1.  Remote Patient Monitoring System Market, by End User, 2021-2030

9.1.1.    Hospital Based Patients

9.1.1.1.        Market Revenue and Forecast (2019-2030)

9.1.2.    Ambulatory Patients

9.1.2.1.        Market Revenue and Forecast (2019-2030)

9.1.3.    Home Healthcare

9.1.3.1.        Market Revenue and Forecast (2019-2030)

Chapter 10.      Global Remote Patient Monitoring System Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, by Product (2019-2030)

10.1.2.  Market Revenue and Forecast, by Application (2019-2030)

10.1.3.  Market Revenue and Forecast, by End User (2019-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, by Product (2019-2030)

10.1.4.2.      Market Revenue and Forecast, by Application (2019-2030)

10.1.4.3.      Market Revenue and Forecast, by End User (2019-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, by Product (2019-2030)

10.1.5.2.      Market Revenue and Forecast, by Application (2019-2030)

10.1.5.3.      Market Revenue and Forecast, by End User (2019-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, by Product (2019-2030)

10.2.2.  Market Revenue and Forecast, by Application (2019-2030)

10.2.3.  Market Revenue and Forecast, by End User (2019-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, by Product (2019-2030)

10.2.4.2.      Market Revenue and Forecast, by Application (2019-2030)

10.2.4.3.      Market Revenue and Forecast, by End User (2019-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, by Product (2019-2030)

10.2.5.2.      Market Revenue and Forecast, by Application (2019-2030)

10.2.5.3.      Market Revenue and Forecast, by End User (2019-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, by Product (2019-2030)

10.2.6.2.      Market Revenue and Forecast, by Application (2019-2030)

10.2.6.3.      Market Revenue and Forecast, by End User (2019-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, by Product (2019-2030)

10.2.7.2.      Market Revenue and Forecast, by Application (2019-2030)

10.2.7.3.      Market Revenue and Forecast, by End User (2019-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, by Product (2019-2030)

10.3.2.  Market Revenue and Forecast, by Application (2019-2030)

10.3.3.  Market Revenue and Forecast, by End User (2019-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, by Product (2019-2030)

10.3.4.2.      Market Revenue and Forecast, by Application (2019-2030)

10.3.4.3.      Market Revenue and Forecast, by End User (2019-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, by Product (2019-2030)

10.3.5.2.      Market Revenue and Forecast, by Application (2019-2030)

10.3.5.3.      Market Revenue and Forecast, by End User (2019-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, by Product (2019-2030)

10.3.6.2.      Market Revenue and Forecast, by Application (2019-2030)

10.3.6.3.      Market Revenue and Forecast, by End User (2019-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, by Product (2019-2030)

10.3.7.2.      Market Revenue and Forecast, by Application (2019-2030)

10.3.7.3.      Market Revenue and Forecast, by End User (2019-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, by Product (2019-2030)

10.4.2.  Market Revenue and Forecast, by Application (2019-2030)

10.4.3.  Market Revenue and Forecast, by End User (2019-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, by Product (2019-2030)

10.4.4.2.      Market Revenue and Forecast, by Application (2019-2030)

10.4.4.3.      Market Revenue and Forecast, by End User (2019-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, by Product (2019-2030)

10.4.5.2.      Market Revenue and Forecast, by Application (2019-2030)

10.4.5.3.      Market Revenue and Forecast, by End User (2019-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, by Product (2019-2030)

10.4.6.2.      Market Revenue and Forecast, by Application (2019-2030)

10.4.6.3.      Market Revenue and Forecast, by End User (2019-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, by Product (2019-2030)

10.4.7.2.      Market Revenue and Forecast, by Application (2019-2030)

10.4.7.3.      Market Revenue and Forecast, by End User (2019-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, by Product (2019-2030)

10.5.2.  Market Revenue and Forecast, by Application (2019-2030)

10.5.3.  Market Revenue and Forecast, by End User (2019-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, by Product (2019-2030)

10.5.4.2.      Market Revenue and Forecast, by Application (2019-2030)

10.5.4.3.      Market Revenue and Forecast, by End User (2019-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, by Product (2019-2030)

10.5.5.2.      Market Revenue and Forecast, by Application (2019-2030)

10.5.5.3.      Market Revenue and Forecast, by End User (2019-2030)

Chapter 11.  Company Profiles

11.1.              Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Nihon Kohden Corporation

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Omron Corporation

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              OSI Systems, Inc.

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              Koninklijke Philips N.V.

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              F. Hoffmann-La Roche Ltd

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Welch Allyn

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Smiths Medical

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              Abbott

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.           Boston Scientific Corporation

11.10.1.               Company Overview

11.10.2.               Product Offerings

11.10.3.               Financial Performance

11.10.4.               Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

13.2.              Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/39198

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com